Posted On: 11/18/2014 9:06:19 AM
Post# of 250616
Merck (MERK) Financials Nov 18, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Merck
Fiscal year is January-December. All values IDR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 751.4B 795.69B 918.53B 929.88B 1.19T
Cost of Goods Sold (COGS) incl. D&A 318.24B 360.01B 442.82B 511.47B 654.14B
COGS excluding D&A 309.61B 348.15B 430.28B 499.08B 641.93B
Depreciation & Amortization Expense 8.63B 11.86B 12.54B 12.39B 12.21B
Depreciation 8.49B - - - 10.66B
Amortization of Intangibles 139.8M - - - 1.55B
Gross Income 433.16B 435.68B 475.71B 418.41B 539.81B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 231.71B 281.94B 277.13B 276.57B 311.59B
Research & Development - - - - -
Other SG&A 231.71B 281.94B 277.13B 276.57B 311.59B
Other Operating Expense 0 0 4.75B 3.14B 0
Unusual Expense 0 0 0 - -
EBIT after Unusual Expense 0 0 0 - -
Non Operating Income/Expense 1.93B 12.61M 84.38B 2.16B 1.39B
Non-Operating Interest Income 5.45B 3.57B 5.02B 5.05B 5.1B
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 899.79M - 0 0 0
Gross Interest Expense 899.79M - 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income 207.93B 157.32B 283.23B 145.91B 234.71B
Income Tax 61.23B 38.52B 52.07B 38.11B 59.26B
Income Tax - Current Domestic 61.72B 40.33B 54.11B 39.17B 62.95B
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (499.54M) (1.8B) (2.04B) (1.07B) (3.68B)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income 146.7B 118.79B 231.16B 107.81B 175.44B
Minority Interest Expense 0 0 0 0 0
Net Income 146.7B 118.79B 231.16B 107.81B 175.44B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 146.7B 118.79B 231.16B 107.81B 175.44B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 146.7B 118.79B 231.16B 107.81B 175.44B
EPS (Basic) 6,549.00 5,303.00 10,320.00 4,813.00 7,832.00
Basic Shares Outstanding 22.4M 22.4M 22.4M 22.4M 22.4M
EPS (Diluted) - - - 4,813.00 7,832.00
Diluted Shares Outstanding - - - 22.4M 22.4M
EBITDA 210.08B 165.6B 206.37B 151.09B 240.43B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Merck
Fiscal year is January-December. All values IDR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 751.4B 795.69B 918.53B 929.88B 1.19T
Cost of Goods Sold (COGS) incl. D&A 318.24B 360.01B 442.82B 511.47B 654.14B
COGS excluding D&A 309.61B 348.15B 430.28B 499.08B 641.93B
Depreciation & Amortization Expense 8.63B 11.86B 12.54B 12.39B 12.21B
Depreciation 8.49B - - - 10.66B
Amortization of Intangibles 139.8M - - - 1.55B
Gross Income 433.16B 435.68B 475.71B 418.41B 539.81B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 231.71B 281.94B 277.13B 276.57B 311.59B
Research & Development - - - - -
Other SG&A 231.71B 281.94B 277.13B 276.57B 311.59B
Other Operating Expense 0 0 4.75B 3.14B 0
Unusual Expense 0 0 0 - -
EBIT after Unusual Expense 0 0 0 - -
Non Operating Income/Expense 1.93B 12.61M 84.38B 2.16B 1.39B
Non-Operating Interest Income 5.45B 3.57B 5.02B 5.05B 5.1B
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 899.79M - 0 0 0
Gross Interest Expense 899.79M - 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income 207.93B 157.32B 283.23B 145.91B 234.71B
Income Tax 61.23B 38.52B 52.07B 38.11B 59.26B
Income Tax - Current Domestic 61.72B 40.33B 54.11B 39.17B 62.95B
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (499.54M) (1.8B) (2.04B) (1.07B) (3.68B)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income 146.7B 118.79B 231.16B 107.81B 175.44B
Minority Interest Expense 0 0 0 0 0
Net Income 146.7B 118.79B 231.16B 107.81B 175.44B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 146.7B 118.79B 231.16B 107.81B 175.44B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 146.7B 118.79B 231.16B 107.81B 175.44B
EPS (Basic) 6,549.00 5,303.00 10,320.00 4,813.00 7,832.00
Basic Shares Outstanding 22.4M 22.4M 22.4M 22.4M 22.4M
EPS (Diluted) - - - 4,813.00 7,832.00
Diluted Shares Outstanding - - - 22.4M 22.4M
EBITDA 210.08B 165.6B 206.37B 151.09B 240.43B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼
